Results 1 to 10 of about 6,997,232 (211)
Current Oncology, 2022 Background: Patients with epithelial ovarian cancer (EOC), treated with niraparib maintenance, present with haematological and gastrointestinal toxicities. Limited data exist on niraparib safety assessment. Objective: To evaluate niraparib safety profile,
Antonia Pagkali +3 more
doaj +3 more sources
Safety profile of India’s influenza vaccine in a large-scale corporate vaccination drive [PDF]
Human Vaccines & ImmunotherapeuticsSeasonal influenza causes substantial morbidity, mortality, and productivity losses worldwide, and although annual vaccination is recommended for adults, coverage in India remains low; corporate vaccination drives may improve access and uptake among ...
Neeraj Khatuja +3 more
doaj +2 more sources
Biomolecules, 2023 Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6is) have transformed the treatment of hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2−) breast cancer over the last decade.
Ioana-Miruna Stanciu +2 more
doaj +3 more sources
Biomolecules, 2021 Imuno TF® is a nutritional supplement composed of isolated transfer factors (TF) from porcine spleen. It is composed of a specific mixture of molecules that impact functions of the biological systems and historically is linked to the immune system ...
Hudson Polonini +3 more
doaj +3 more sources
Pharmaceutics, 2022 The development of nanovectors for precise gene therapy is increasingly focusing on avoiding uncontrolled inflammation while still being able to effectively act on the target sites.
Gabriele Maiorano +9 more
doaj +3 more sources
In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol
Pharmaceuticals, 2022 We characterized the in vitro safety and bioavailability profile of silvestrol, a compound effective against various viruses, such as corona- and Ebolaviruses, with an EC50 value of about 5 nM.
Susanne Schiffmann +11 more
doaj +3 more sources
Tapentadol: an overview of the safety profile
Journal of pain research, 2019 Long-term opioid therapy may be associated with analgesic efficacy and also predictable adverse events, including cardiovascular and pulmonary events, gastrointestinal disorders, endocrinological harms, psychological problems, impairment of driving ...
E. Polati +3 more
semanticscholar +7 more sources
Clinical Rheumatology, 2018 A few studies have reported the safety profile of interleukin (IL)-1 blockers from real life. The aim of this study is to describe anakinra (ANA) and canakinumab (CAN) safety profile in children and adults, based on data from a real-life setting ...
Romina Gallizzi +2 more
exaly +2 more sources
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2022 The aim of the study was to evaluate the efficacy and safety of Kolofort® (a complex medicine containing technologically processed forms of antibodies to S-100 protein, tumor necrosis factor-α and histamine) in the management of functional dyspepsia (FD)
Yu. O. Shulpekova +5 more
doaj +1 more source
The validity of giving adjuvant capecitabine after standard anthracycline and/or taxanes based neo-/adjuvant chemotherapy in early triple-negative breast cancer patients: An Egyptian prospective multicentric phase III trial [PDF]
Egyptian Journal of Cancer and Biomedical Research, 2022 Background: Triple-negative breast cancer (TNBC) is considered an aggressive breast cancer subtype despite giving standard therapies, these patients have high metastatic and relapse rates in addition to short survival.
Marwa Abdelgawad +4 more
doaj +1 more source